Biden's bid for re-election, AHIP takes on Pharma and the digital health's equity problems
Biden announces re-election bid
The announcement was expected. A second Biden administration would mean continued implementation of the healthcare provisions of the Inflation Reduction Act, including CMS drug price negotiation and enhanced ACA subsidies. Any talk of Medicare for all is likley to fade into the background. There's no question that Biden campaign believes it can score points by talking about abortion rights. The fourth image in the three-minute campaign video released this morning featured a women holding a sign saying “abortion is healthcare” and at about the 45-second mark, Biden’s voiceover narration mentions what he called MAGA extremists “dictating what healthcare decisions women can make.”
Heavyweight fight: AHIP vs. Pharma
The health insurers' trade association announced yesterday that it was launching a major advertising campaign. “The ads call out how Big Pharma spends millions pointing fingers at others in the health care system to distract Americans from manufacturers’ soaring drug prices – attempting to deflect blame, limit competition, and undermine patients’ bargaining power,” said the news release.
Digital health and the dangers of leaving some behind
In a Health Affairs Forefront blog post this morning, NYU Grossman School of Medicine faculty and researchers discuss the experience of implementing a digital health program for improved blood pressure management at the Park Ridge Family Health Center, a large federally qualified health center in Brooklyn. “As health systems increasingly rely upon technology-facilitated care beyond the pandemic, patients with limited access to technology and low levels of digital literacy face disenfranchisement from their providers,” they warn. But they also have many suggestions for addressing the problem: regular screening for digital literacy, train community health workers for digital outreach, create tipsheets written at 6th grade level and streamline onboarding to eliminate the need for multiple apps.
...and from the inbox
From Stat: Elevance (the health insurer formerly known as Anthem) plowed $3.6 million into lobbying during the first quarter of 2023. And Morphic Therapeutics is reporting positive results for its ulcerative colitis drug.
From Axios Vitals: The morning healthcare newsletter leads with news about efforts to combat Lyme vaccine, which includes two mRNA vaccines in Moderna’s pipeline and the possibility of Lyme disease preexposure prophylaxis (PrEP).
From KFF Health News: The health news organization (formerly known as Kaiser Health News) posted a piece this morning about possible connections between air pollution and mental health. The reporter points to Lilian Calderón-Garcidueñas’s study of brains of 203 Mexico City residents and evidence of neurodegeneration and possible link to exposure to air pollution: “Sussing out the impact of air pollution on the brain has been more difficult than for other organs because of its inaccessibility, so it has not been researched as thoroughly, according to researchers. Whether air pollution may cause or contribute to Alzheimer’s or Parkinson’s is not settled science. But Calderón-Garcidueñas’ work is at the leading edge of showing that air pollution goes directly into the brain through the air we breathe, and has serious impacts.”
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
With aging populations, osteoporosis rates are set to increase, and researchers are looking for the next innovative drug to help prevent or manage the bone disease as there is currently no drug that completely does so effectively, according to a recent study published in Advanced Science.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More